| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Epidemiology |
1 Northern California Cancer Center, Fremont, California; 2 Comprehensive Cancer Center, Wake Forest University, Winston-Salem, North Carolina; and 3 Keck School of Medicine, University of Southern California, Los Angeles, California
Requests for reprints: Esther M. John, Northern California Cancer Center, 2201 Walnut Avenue, Suite 300, Fremont, CA 94538. Phone: 510-608-5007; Fax: 510-608-5085; E-mail: ejohn{at}nccc.org.
Substantial experimental evidence indicates that the hormonal form of vitamin D promotes the differentiation and inhibits the proliferation, invasiveness, and metastasis of human prostatic cancer cells. Results from epidemiologic studies of vitamin D status and/or vitamin D receptor (VDR) polymorphisms and prostate cancer risk have been mixed. We conducted a population-based, case-control study of advanced prostate cancer among men ages 40 to 79 years from the San Francisco Bay area. Interview data on lifetime sun exposure and other risk factors were collected for 905 non-Hispanic White men (450 cases and 455 controls). Using a reflectometer, we measured constitutive skin pigmentation on the upper underarm (a sun-protected site) and facultative pigmentation on the forehead (a sun-exposed site) and calculated a sun exposure index from these measurements. Biospecimens were collected for 426 cases and 440 controls. Genotyping was done for VDR polymorphisms in the 5' regulatory region (Cdx-2), exon 2 (FokI), and the 3' region (TaqI and BglI). Reduced risk of advanced prostate cancer was associated with high sun exposure determined by reflectometry [odds ratio (OR), 0.51; 95% confidence interval (95% CI), 0.33-0.80] and high occupational outdoor activity (OR, 0.73; 95% CI, 0.48-1.11). Significant risk reductions with the high-activity alleles FokI FF or Ff, TaqI tt, and BglI BB genotypes and a nonsignificant reduction with Cdx-2 AG or AA genotype were observed in the presence of high sun exposure, with ORs ranging from 0.46 to 0.67. Our findings support the hypothesis that sun exposure and VDR polymorphisms together play important roles in the etiology of prostate cancer.
This article has been cited by other articles:
![]() |
J. L. Lapp Vitamin D: Bone Health and Beyond American Journal of Lifestyle Medicine, September 1, 2009; 3(5): 386 - 393. [Abstract] [PDF] |
||||
![]() |
K. KOSTNER, N. DENZER, C. S.L. MULLER, R. KLEIN, W. TILGEN, and J. REICHRATH The Relevance of Vitamin D Receptor (VDR) Gene Polymorphisms for Cancer: A Review of the Literature Anticancer Res, September 1, 2009; 29(9): 3511 - 3536. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. VIETH How to Optimize Vitamin D Supplementation to Prevent Cancer, Based on Cellular Adaptation and Hydroxylase Enzymology Anticancer Res, September 1, 2009; 29(9): 3675 - 3684. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Dickinson, D. Perera, A. van der Mei, A-L Ponsonby, A. Polanowski, R. Thomson, B. Taylor, J. McKay, J Stankovich, and T Dwyer Past environmental sun exposure and risk of multiple sclerosis: a role for the Cdx-2 Vitamin D receptor variant in this interaction Multiple Sclerosis, May 1, 2009; 15(5): 563 - 570. [Abstract] [PDF] |
||||
![]() |
J. N. P. Rohan and N. L. Weigel 1{alpha},25-Dihydroxyvitamin D3 Reduces c-Myc Expression, Inhibiting Proliferation and Causing G1 Accumulation in C4-2 Prostate Cancer Cells Endocrinology, May 1, 2009; 150(5): 2046 - 2054. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ahn, D. Albanes, S. I. Berndt, U. Peters, N. Chatterjee, N. D. Freedman, C. C. Abnet, W.-Y. Huang, A. S. Kibel, E.D. Crawford, et al. Vitamin D-related genes, serum vitamin D concentrations and prostate cancer risk Carcinogenesis, May 1, 2009; 30(5): 769 - 776. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Bouillon, G. Carmeliet, L. Verlinden, E. van Etten, A. Verstuyf, H. F. Luderer, L. Lieben, C. Mathieu, and M. Demay Vitamin D and Human Health: Lessons from Vitamin D Receptor Null Mice Endocr. Rev., October 1, 2008; 29(6): 726 - 776. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Zuccolo, R. Harris, D. Gunnell, S. Oliver, J. A. Lane, M. Davis, J. Donovan, D. Neal, F. Hamdy, R. Beynon, et al. Height and Prostate Cancer Risk: A Large Nested Case-Control Study (ProtecT) and Meta-analysis Cancer Epidemiol. Biomarkers Prev., September 1, 2008; 17(9): 2325 - 2336. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Ochs-Balcom, M. S. Cicek, C. L. Thompson, T. C. Tucker, R. C. Elston, S. J.Plummer, G. Casey, and L. Li Association of vitamin D receptor gene variants, adiposity and colon cancer Carcinogenesis, September 1, 2008; 29(9): 1788 - 1793. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.-L. Ponsonby, A. Pezic, J. Ellis, R. Morley, F. Cameron, J. Carlin, and T. Dwyer Variation in Associations between Allelic Variants of the Vitamin D Receptor Gene and Onset of Type 1 Diabetes Mellitus by Ambient Winter Ultraviolet Radiation Levels: A Meta-Regression Analysis Am. J. Epidemiol., August 15, 2008; 168(4): 358 - 365. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Kote-Jarai, D. F. Easton, J. L. Stanford, E. A. Ostrander, J. Schleutker, S. A. Ingles, D. Schaid, S. Thibodeau, T. Dork, D. Neal, et al. Multiple Novel Prostate Cancer Predisposition Loci Confirmed by an International Study: The PRACTICAL Consortium Cancer Epidemiol. Biomarkers Prev., August 1, 2008; 17(8): 2052 - 2061. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ahn, U. Peters, D. Albanes, M. P. Purdue, C. C. Abnet, N. Chatterjee, R. L. Horst, B. W. Hollis, W.-Y. Huang, J. M. Shikany, et al. Serum Vitamin D Concentration and Prostate Cancer Risk: A Nested Case-Control Study J Natl Cancer Inst, June 4, 2008; 100(11): 796 - 804. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. C. Torkko, A. van Bokhoven, P. Mai, J. Beuten, I. Balic, T. E. Byers, J. E. Hokanson, J. M. Norris, A. E. Baron, M. S. Lucia, et al. VDR and SRD5A2 Polymorphisms Combine to Increase Risk for Prostate Cancer in Both Non-Hispanic White and Hispanic White Men Clin. Cancer Res., May 15, 2008; 14(10): 3223 - 3229. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. John, G. G. Schwartz, J. Koo, W. Wang, and S. A. Ingles Sun Exposure, Vitamin D Receptor Gene Polymorphisms, and Breast Cancer Risk in a Multiethnic Population Am. J. Epidemiol., December 15, 2007; 166(12): 1409 - 1419. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Xu, F. Fang, D. K. St. Clair, S. Josson, P. Sompol, I. Spasojevic, and W. H. St. Clair Suppression of RelB-mediated manganese superoxide dismutase expression reveals a primary mechanism for radiosensitization effect of 1{alpha},25-dihydroxyvitamin D3 in prostate cancer cells Mol. Cancer Ther., July 1, 2007; 6(7): 2048 - 2056. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. John, J. Koo, and G. G. Schwartz Sun Exposure and Prostate Cancer Risk: Evidence for a Protective Effect of Early-Life Exposure Cancer Epidemiol. Biomarkers Prev., June 1, 2007; 16(6): 1283 - 1286. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. E. Mullin and A. Dobs Vitamin D and Its Role in Cancer and Immunity: A Prescription for Sunlight Nutr Clin Pract, June 1, 2007; 22(3): 305 - 322. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. de Vries, I. Soerjomataram, S. Houterman, M. W. J. Louwman, and J. W. W. Coebergh Decreased Risk of Prostate Cancer after Skin Cancer Diagnosis: A Protective Role of Ultraviolet Radiation? Am. J. Epidemiol., April 15, 2007; 165(8): 966 - 972. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Cicek, X. Liu, F. R. Schumacher, G. Casey, and J. S. Witte Vitamin D Receptor Genotypes/Haplotypes and Prostate Cancer Risk Cancer Epidemiol. Biomarkers Prev., December 1, 2006; 15(12): 2549 - 2552. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Freedman, C. A. Haiman, N. Patterson, G. J. McDonald, A. Tandon, A. Waliszewska, K. Penney, R. G. Steen, K. Ardlie, E. M. John, et al. From the Cover: Admixture mapping identifies 8q24 as a prostate cancer risk locus in African-American men PNAS, September 19, 2006; 103(38): 14068 - 14073. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. G. Schwartz and W. J. Blot Vitamin d status and cancer incidence and mortality: something new under the sun. J Natl Cancer Inst, April 5, 2006; 98(7): 428 - 430. [Full Text] [PDF] |
||||
![]() |
E. Giovannucci, Y. Liu, E. B. Rimm, B. W. Hollis, C. S. Fuchs, M. J. Stampfer, and W. C. Willett Prospective study of predictors of vitamin d status and cancer incidence and mortality in men. J Natl Cancer Inst, April 5, 2006; 98(7): 451 - 459. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |